Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04907344 | Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) | unknown | Phase 2 / Phase 3 | 420 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 28, 2021 | clinicaltrials |
| NCT04240548 | Radiation Therapy for ypN0 Breast Cancer | unknown | Phase 3 | 160 | National Cancer Institute, EgyptOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04803266 | Elective Internal Mammary Node Irradiation in Women With Node-positive Breast Cancer | unknown | Phase 3 | 747 | Yonsei UniversityOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT03417622 | Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy | unknown | Phase 3 | 370 | Mansoura UniversityOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT04300829 | Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer Patients(CICA-RT) | unknown | Phase 3 | 248 | Centre Leon BerardOTHER | 1 | Feb 4, 2021 | clinicaltrials |
| NCT04736186 | Prevention and Treatment of Pyrrolitinib-associated Diarrhea | unknown | Phase 2 / Phase 3 | 470 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT04705909 | Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer | unknown | Phase 2 / Phase 3 | 60 | Mansoura UniversityOTHER | 1 | Jan 12, 2021 | clinicaltrials |
| NCT04665986 | Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer | unknown | Phase 3 | 50 | Zhejiang Cancer HospitalOTHER | 0 | Dec 14, 2020 | clinicaltrials |
| NCT01917279 | Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC(CAMELLIA) | unknown | Phase 3 | 280 | Binghe XuUNKNOWN | 1 | Jul 23, 2020 | clinicaltrials |
| NCT04387630 | Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer. | unknown | Phase 2 / Phase 3 | 120 | Mansoura UniversityOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04403529 | Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer | unknown | Phase 3 | 200 | Fudan UniversityOTHER | 1 | Jun 1, 2020 | clinicaltrials |
| NCT04405505 | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC) | unknown | Phase 3 | 332 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT04337658 | Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer(FAVOR) | unknown | Phase 3 | 493 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 8, 2020 | clinicaltrials |
| NCT02879513 | Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy | unknown | Phase 3 | 290 | RenJi HospitalOTHER | 1 | Mar 23, 2020 | clinicaltrials |
| NCT04307147 | NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy | unknown | Phase 3 | 316 | Fudan UniversityOTHER | 1 | Mar 13, 2020 | clinicaltrials |
| NCT01758146 | Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors | unknown | Phase 3 | 412 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Mar 4, 2020 | clinicaltrials |
| NCT00541086 | Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery | unknown | Phase 3 | 3,697 | Gruppo Italiano Mammella (GIM)OTHER | 1 | Feb 7, 2020 | clinicaltrials |
| NCT02759783 | Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases(CORE) | unknown | Phase 2 / Phase 3 | 245 | Royal Marsden NHS Foundation TrustOTHER | 2 | Aug 21, 2019 | clinicaltrials |
| NCT03971019 | Survival Benefits of Statins in Breast Cancer Patients(SBSBC) | unknown | Phase 3 | 314 | Peking Union Medical College HospitalOTHER | 1 | Aug 14, 2019 | clinicaltrials |
| NCT01907529 | A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer(TENDENCY) | unknown | Phase 2 / Phase 3 | 300 | Hebei Medical University Fourth HospitalOTHER | 1 | Aug 9, 2019 | clinicaltrials |
| NCT04046159 | Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ | unknown | Phase 3 | 810 | National Taiwan University HospitalOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT03544762 | Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation(breast) | unknown | Phase 3 | 60 | National Taiwan University HospitalOTHER | 1 | May 30, 2019 | clinicaltrials |
| NCT03949634 | Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD) | unknown | Phase 3 | 272 | Fudan UniversityOTHER | 1 | May 14, 2019 | clinicaltrials |
| NCT03876886 | The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency | unknown | Phase 3 | 200 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT00532727 | Triple Negative Breast Cancer Trial(TNT) | unknown | Phase 3 | 400 | Institute of Cancer Research, United KingdomOTHER | 1 | Feb 20, 2019 | clinicaltrials |
| NCT02751606 | Nano MRI on 7 Tesla in Rectal and Breast Cancer | unknown | Phase 3 | 30 | Radboud University Medical CenterOTHER | 1 | Dec 6, 2018 | clinicaltrials |
| NCT03731026 | The LightPath® and 68Ga-RM2 in Breast Cancer Study | unknown | Phase 3 | 80 | Lightpoint Medical LimitedINDUSTRY | 1 | Nov 6, 2018 | clinicaltrials |
| NCT03696004 | Outcome of Neo-adjuvant Chemotherapy Followed by Breast Conservative Surgery in Breast Cancer in Upper Egypt | unknown | Phase 2 / Phase 3 | 45 | Assiut UniversityOTHER | 1 | Oct 4, 2018 | clinicaltrials |
| NCT01104571 | Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer(EPHOS-B) | unknown | Phase 3 | 257 | Institute of Cancer Research, United KingdomOTHER | 1 | Sep 17, 2018 | clinicaltrials |
| NCT00301925 | Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery(TACT2) | unknown | Phase 3 | 4,400 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT02898376 | Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer(FIBROTHERME) | unknown | Phase 3 | 142 | Institut de Cancérologie de LorraineOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT03606369 | Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer. | unknown | Phase 2 / Phase 3 | 560 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Jul 30, 2018 | clinicaltrials |
| NCT03566394 | Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy | unknown | Phase 2 / Phase 3 | 46 | British Columbia Cancer AgencyOTHER | 0 | Jun 25, 2018 | clinicaltrials |
| NCT03518957 | 12-week Exercise Intervention Program Versus Observation in Early Stage Breast Cancer Patients on the Impact on Mental Health, Quality of Life and Immune Markers | unknown | Phase 3 | 304 | National University Hospital, SingaporeOTHER | 1 | May 14, 2018 | clinicaltrials |
| NCT03507465 | Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer | unknown | Phase 2 / Phase 3 | 290 | Guangdong Provincial People's HospitalOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT03491410 | Breast Cancer Active Surveillance, Alternative Option, Aspirin Included | unknown | Phase 2 / Phase 3 | 60 | Centro Hospitalar Lisboa OcidentalOTHER_GOV | 0 | Apr 9, 2018 | clinicaltrials |
| NCT03423849 | The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy | unknown | Phase 2 / Phase 3 | 200 | Zhiyong YuOTHER | 0 | Feb 6, 2018 | clinicaltrials |
| NCT03404752 | Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients. | unknown | Phase 3 | 120 | Gema Biotech S.A.INDUSTRY | 1 | Jan 19, 2018 | clinicaltrials |
| NCT03385200 | KVUS at Neoadjuvant CTx of Breast Cancer | unknown | Phase 3 | 60 | RWTH Aachen UniversityOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT03373708 | Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer | unknown | Phase 2 / Phase 3 | 200 | Zhiyong YuOTHER | 0 | Dec 18, 2017 | clinicaltrials |
| NCT03351062 | Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer | unknown | Phase 3 | 844 | Chinese Anti-Cancer AssociationOTHER | 1 | Nov 22, 2017 | clinicaltrials |
| NCT03349177 | Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy | unknown | Phase 2 / Phase 3 | 200 | Zhiyong YuOTHER | 0 | Nov 21, 2017 | clinicaltrials |
| NCT03319069 | Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer | unknown | Phase 3 | 60 | Ahmed AhmOTHER | 1 | Oct 24, 2017 | clinicaltrials |
| NCT00408408 | Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery | unknown | Phase 3 | 1,206 | NSABP Foundation IncNETWORK | 3 | Sep 18, 2017 | clinicaltrials |
| NCT03275727 | A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast Cancer(INNOVBC) | unknown | Phase 2 / Phase 3 | 128 | Linkoeping UniversityOTHER_GOV | 0 | Sep 8, 2017 | clinicaltrials |
| NCT03085368 | A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin | unknown | Phase 2 / Phase 3 | 482 | Peking Union Medical College HospitalOTHER | 1 | Jul 28, 2017 | clinicaltrials |
| NCT01222052 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients(NNBC3-Europe) | unknown | Phase 3 | 4,150 | Martin-Luther-Universität Halle-WittenbergOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT02761460 | The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia | unknown | Phase 3 | 338 | wang shusenOTHER | 1 | Jun 1, 2017 | clinicaltrials |
| NCT01642771 | Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer | unknown | Phase 3 | 636 | China Breast Cancer Clinical Study GroupOTHER | 1 | Apr 19, 2017 | clinicaltrials |
| NCT03006614 | PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer(PERS) | unknown | Phase 3 | 320 | Shi YanxiaOTHER | 1 | Jan 16, 2017 | clinicaltrials |
Data updated 23 days agoSource updated May 28, 2021source: clinicaltrials